NEW YORK (GenomeWeb News) – CompanionDx Reference Lab and Enable Healthcare have partnered to provide physicians in Enable's network access to CompanionDx's pharmacogenomics testing.

Enable's physicians will use CompanionDx's services to make better informed decisions about patient therapies and medications and to identify poor and ultra-rapid metabolizers of drugs, CompanionDx said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.